Advertisement

BIOL

BIOLASE, Inc.

Healthcare · USD

Set alert

Price alert · BIOL

All alert types
0.02 USD 0.00 0.00%
As of Oct 2, 2024
0.0157 Day range 0.052
0.04 52-week range 9.35
Open
0.049
Prev close
0.02
Mkt cap
2.59M
Vol
2.67M
Avg vol
2.03M
EPS
-11.97
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0157
High
0.052
Forward P/E
-0.86
Beta
0.72
Short ratio
1.09
Inst. own
8.97%
Dividend
0.00
Ex-div date
Jun 23, 2005
Earnings
Nov 14, 2024
50-d avg
0.1336
200-d avg
0.66915
1y target
1.95

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BIOL has not been loaded yet. Try again in a moment.

Ownership

Held by insiders 0.33%
Held by institutions 8.97%
Float held by institutions 9.00%
Institutions 20

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Walleye Capital LLC1.36%14,205100.43KJun 29, 2023
Zhang Financial LLC1.16%12,07822.46KSep 29, 2023
Acadian Asset Management. LLC0.92%9,61767.99KJun 29, 2023
Avantax Planning Partners, Inc.0.52%5,44138.47KJun 29, 2023
Millennium Management Llc0.39%4,06828.76KJun 29, 2023
Perkins Capital Management, Inc.0.15%1,57211.11KJun 29, 2023

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.09%9266.55KJun 29, 2023
Fidelity Extended Market Index Fund0.03%2922.38KMay 30, 2023
Fidelity Series Total Market Index Fund0.01%68554May 30, 2023
Fidelity Total Market Index Fund0.01%107872May 30, 2023
BIOL insiders
InsiderRelationLatest transactionDateShares held
BEAVER JOHN RChief Executive OfficerPurchaseNov 29, 2021621,530
CLARK PAUL NDirectorConversion of Exercise of derivative securityJun 29, 20170
FEINBERG LARRY NBeneficial Owner of more than 10% of a Class of SecuritySaleJun 8, 20200
FLYNN HAROLD C JRChief Executive OfficerConversion of Exercise of derivative securityDec 4, 20170
LORD JONATHAN T.DirectorSaleDec 6, 202259,925
NORBE TODD AChief Executive OfficerPurchaseDec 12, 201815,000
Advertisement